Clinical trials
Phase 3 Purpura, Thrombocytopenic, Idiopathic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 7 |
| Recruiting | 5 |
| Withdrawn | 4 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shandong University | 15 |
| Novartis Pharmaceuticals | 3 |
| argenx | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Peking University People's Hospital | 2 |
| Takeda | 2 |
| UCB Biopharma SRL | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| GlaxoSmithKline | 1 |
| Hutchmed | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 38 |
| Purpura | 10 |
| Thrombocytopenia | 6 |
| Autoimmune Diseases | 2 |
| Blood Platelet Disorders | 2 |
| Cytopenia | 2 |
| Hematologic Diseases | 2 |
| Hemorrhage | 2 |
| Hemorrhagic Disorders | 2 |
| Immune System Diseases | 2 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.